09.15.23
Alastin Skincare’s new C-Radical Defense Antioxidant Serum is powered a proprietary encapsulated vitamin C (sodium ascorbate) and 14 antioxidants that the brand says provides a new option in antioxidant serums.
The clinically proven serum helps protect against environmental stressors, combatting free radicals, UV damage, blue light, and pollution while supporting the skin's ability to conserve elastin for skin that looks smoother, and more radiant, according to Galderma, parent company of Alastin.
It addresses what Galderma calls an unmet demand among individuals seeking a vitamin C product that not only helps protect against environmental damage and helps enhance skin's appearance, but also has shown exceptional stability, absorption, and a pleasant user experience.
In a 12-week clinical study, results showed subject improvement in the appearance of skin's texture, tone, and luminosity, while helping to reduce the appearance of fine lines, wrinkles, photodamage, and other signs of aging in as early as 8 weeks. In addition, C-Radical helps reduce the effects of free radicals in the skin by up to 74%.
“This serum truly marks a significant step forward in skincare innovation from Galderma,” noted Galderma Chief Scientific Officer Alan D. Widgerow, MBBCh; MMed; FCS; FACS. Widgerow is also head of Skin Science Center for Innovation and head of Alastin Innovations.
Galderma completed its acquisition of Alastin in January 2022.
The clinically proven serum helps protect against environmental stressors, combatting free radicals, UV damage, blue light, and pollution while supporting the skin's ability to conserve elastin for skin that looks smoother, and more radiant, according to Galderma, parent company of Alastin.
It addresses what Galderma calls an unmet demand among individuals seeking a vitamin C product that not only helps protect against environmental damage and helps enhance skin's appearance, but also has shown exceptional stability, absorption, and a pleasant user experience.
In a 12-week clinical study, results showed subject improvement in the appearance of skin's texture, tone, and luminosity, while helping to reduce the appearance of fine lines, wrinkles, photodamage, and other signs of aging in as early as 8 weeks. In addition, C-Radical helps reduce the effects of free radicals in the skin by up to 74%.
“This serum truly marks a significant step forward in skincare innovation from Galderma,” noted Galderma Chief Scientific Officer Alan D. Widgerow, MBBCh; MMed; FCS; FACS. Widgerow is also head of Skin Science Center for Innovation and head of Alastin Innovations.
Galderma completed its acquisition of Alastin in January 2022.